申请人:BOEHRINGER INGELHEIM INT
公开号:WO2009112565A1
公开(公告)日:2009-09-17
The present invention encompasses compounds of general formula (1) wherein R1 to R3 are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and the use thereof for preparing a medicament having the above-mentioned properties.
本发明涵盖了一般式(1)中R1至R3的化合物,其中R1至R3的定义如权利要求书中所述,适用于治疗以细胞过度或异常增殖为特征的疾病,并用于制备具有上述特性的药物。